PONSTAN - Medsafe
2. Patients in whom aspirin and/or other NSAIDs have induced symptoms of bronchospasm, allergic rhinitis or urticaria because the potential exists for cross-
Download PONSTAN - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Argatroban for anticoagulation in continuous renal ...
www.nimbot.comline, or a platelet count lower than 100 109/L while on heparin therapy, or by positive local laboratory tests. HIT-II screening tests were performed at the University Hospital
DRUG NAME: Cisplatin
www.bccancer.bc.caCisplatin DRUG NAME: Cisplatin SYNONYM: CDDP ,1 cis-Diamminedichloroplatinum 2dichlorodiammineplatinum(II) 3 Patinum II DDP 4 COMMON TRADE NAME: PLATINOL ®; …
190.12 Urine Culture, Bacterial CPT Code: 87086 …
www.shiel.com190.12 Urine Culture, Bacterial CPT Code: 87086 87088 87184 87186 Medicare National Coverage Determination Policy ICD10 DESCRIPTION
Intravenous iodinated contrast media and …
www.webcir.orgIntravenous iodinated contrast media and metformin general poor health, hyper-ventilation, hypotension, vomiting, abdominal pain and stupor. The diagnosis
Treatment of UTIs in patients with renal failure
www.druginformation.co.nzThe information contained within this bulletin is provided on the understanding that although it may be used to assist in your final clinical decision, the Drug Information Service at Christchurch Hospital does not accept any responsibility for such decisions.
Spiractin - Medicines
www.medicines.org.auSpiractin – Product Information 3 Nephrotic syndrome.Although glucocorticoids, whose anti-inflammatory activity appears to benefit the primary pathological process in the renal glomerulus, should probably be employed first, spironolactone either alone or
DRUG NAME: Fludarabine - BC Cancer
www.bccancer.bc.ca*Leukemia, chronic lymphocytic . Conditioning regimen pre-allogeneic bone marrow transplant: 2 Leukemia, prolymphocytic. 3 Leukemia, acute myeloid. 5 …
FBC and blood film. Renal/liver/bone panel, LDH, …
www.londoncanceralliance.nhs.uk1.24 low dose ara-c Version 1.2.doc Page 1 of 2 1 Acute Myeloid Leukaemia 1.24 Low Dose Cytarabine Indication • Non-Intensive Chemotherapy. Pre-treatment Evaluation
NAC (N-acetylcysteine) Hydration Oral NAC dosing …
www.nimbot.comDispensing and Administration Guidelines for CIN (Contrast Induced Nephropathy) NAC (N-acetylcysteine) + Hydration Oral NAC dosing Hydration Give …
Related search queries
Argatroban for anticoagulation in continuous renal, DRUG NAME: Cisplatin, 87186 Medicare National Coverage Determination Policy, Intravenous iodinated contrast media and, Treatment of UTIs in patients with renal failure, Drug, Spiractin, Renal, DRUG NAME: Fludarabine, Acute, N-acetylcysteine) Hydration Oral NAC dosing, Induced, N-acetylcysteine) + Hydration Oral NAC dosing